Skip to content

Adhera Therapeutics, Inc.: filings

Every Adhera Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 50 filings, each linked to its SEC index.

Filing record ends 2023-11-20

The latest filing in this captured record is a 10-Q filed 2023-11-20. No later filing is in the SEC companyfacts record captured on 2026-09-22. Adhera Therapeutics, Inc. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2023-11-20fiscal Q3 202326830001493152-23-042138
10-Q2023-08-21fiscal Q2 202325750001493152-23-029594
10-Q2023-05-22fiscal Q1 202323470001493152-23-018516
10-K2023-03-31fiscal FY 202226500001493152-23-010160
10-Q2022-11-14fiscal Q3 202225750001493152-22-031940
10-Q2022-08-15fiscal Q2 202225710001493152-22-022832
10-Q2022-05-16fiscal Q1 202222450001493152-22-013775
10-K2022-04-15fiscal FY 202123440001493152-22-010064
10-Q2021-11-22fiscal Q3 202123660001493152-21-029537
10-Q2021-08-23fiscal Q2 202122620001493152-21-020974
10-Q2021-05-24fiscal Q1 202121440001493152-21-012758
10-K2021-04-07fiscal FY 202027490001493152-21-008190
10-Q2020-11-18fiscal Q3 202029740001493152-20-021944
10-Q2020-08-19fiscal Q2 202028800000737207-20-000030
10-Q2020-07-06fiscal Q1 202028600000737207-20-000023
10-K2020-04-14fiscal FY 201938760000737207-20-000006
10-Q2019-11-19fiscal Q3 2019381050000737207-19-000004
10-Q2019-08-14fiscal Q2 201939910001493152-19-012598
10-Q2019-05-15fiscal Q1 201934610001493152-19-007405
10-K2019-04-16fiscal FY 201841680001493152-19-005482
10-Q2018-11-19fiscal Q3 201836760001493152-18-016490
10-Q2018-08-10fiscal Q2 201833730001493152-18-011410
10-Q2018-05-18fiscal Q1 201828510001493152-18-007462
10-K2018-04-17fiscal FY 201730580001493152-18-005372
10-Q2017-11-13fiscal Q3 201729680001493152-17-012923
10-Q2017-08-14fiscal Q2 201728630001493152-17-009023
10-Q2017-05-15fiscal Q1 201727470001493152-17-005362
10-K2017-03-31fiscal FY 201630540001493152-17-003272
10-Q2016-11-21fiscal Q3 201629770001493152-16-015309
10-Q2016-08-15fiscal Q2 201625710001571049-16-017466
10-Q2016-05-16fiscal Q1 201625520001571049-16-015338
10-K2016-03-30fiscal FY 201527540001571049-16-013489
10-Q2015-11-16fiscal Q3 201527770001571049-15-009330
10-Q2015-08-13fiscal Q2 201527770001571049-15-006715
10-Q2015-05-14fiscal Q1 201526540001571049-15-004211
10-K2015-02-18fiscal FY 201425500001571049-15-001227
10-Q2014-11-14fiscal Q3 201427760001571049-14-006407
10-Q2014-08-19fiscal Q2 201428770001571049-14-004137
10-Q2014-08-19fiscal Q1 201428560001571049-14-004127
10-Q2014-08-07fiscal Q3 201328750001571049-14-003767
10-Q2014-08-07fiscal Q2 201328760001571049-14-003766
10-Q2014-08-07fiscal Q1 201328550001571049-14-003765
10-K2014-08-05fiscal FY 201327550001571049-14-003630
10-K2014-07-22fiscal FY 201231580001571049-14-003110
10-Q2012-12-05fiscal Q3 201227610001144204-12-066564
10-Q2012-12-05fiscal Q2 201230760001144204-12-066541
10-Q2012-12-05fiscal Q1 201226500001144204-12-066533
10-K2012-10-10fiscal FY 201131630001144204-12-055514
10-Q2011-11-10fiscal Q3 201129700001193125-11-305658
10-Q2011-08-11fiscal Q2 201129700001193125-11-219645

Inspect the source

Entity
Adhera Therapeutics, Inc. / CIK 0000737207
Captured
SEC response SHA-256
b4aa163aa5766f2d921484473caaa9f0b2c20249a855398a2d3c8607f35860b4

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000737207.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))